Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Intuitive, Siemens Healthineers boost integration for Ion Endoluminal procedure » 09:20
06/30/22
06/30
09:20
06/30/22
09:20
ISRG

Intuitive Surgical

$202.66 /

+0.605 (+0.30%)

, SMMNY

Siemens Healthineers

$24.70 /

-0.14 (-0.56%)

Intuitive (ISRG)…

Intuitive (ISRG) announced the U.S. Food and Drug Administration has cleared the integration of a mobile cone-beam CT, CBCT, imaging technology and the Ion Endoluminal System used for robotic-assisted bronchoscopy. Siemens Healthineers (SMMNY) Cios Spin mobile imaging offers integrated functionality with Ion to provide 2D and 3D imaging during procedures to help physicians gain confidence around refining Ion's catheter positioning and help improve biopsy tool placement. Early studies have shown Ion enables a diagnostic yield of approximately 80% in studies with a relatively small average nodule size. 3D imaging is used in peripheral nodule biopsies to confirm that biopsy tools are appropriately placed in a suspicious nodule. An initial single center study demonstrated an improvement in diagnostic yield of up to approximately 10% when the Cios Spin was used with the Ion platform. This new imaging integration could help improve the accuracy of biopsy procedures, a key step in how lung cancer gets diagnosed. Lung cancer kills more people annually than any other cancer and early diagnosis can improve survival rates. The integration enhances a physician's ability to provide minimally invasive lung biopsy with the Ion system, which can give patients answers sooner.

ShowHide Related Items >><<
ISRG Intuitive Surgical
$202.66 /

+0.605 (+0.30%)

ISRG Intuitive Surgical
$202.66 /

+0.605 (+0.30%)

06/22/22 Deutsche Bank
Intuitive Surgical price target lowered to $225 from $300 at Deutsche Bank
05/17/22 Citi
Intuitive Surgical price target lowered to $305 from $360 at Citi
04/22/22 Evercore ISI
Intuitive Surgical price target lowered to $280 from $294 at Evercore ISI
04/22/22 Raymond James
Intuitive Surgical price target lowered to $330 from $334 at Raymond James
SMMNY Siemens Healthineers
$24.70 /

-0.14 (-0.56%)

05/31/22 Barclays
Siemens Healthineers upgraded to Overweight from Equal Weight at Barclays
05/05/22 JPMorgan
Siemens Healthineers price target lowered to EUR 69.40 at JPMorgan
03/31/22 Deutsche Bank
Siemens Healthineers price target lowered to EUR 71 at Deutsche Bank
03/14/22 Kepler Cheuvreux
Siemens Healthineers upgraded to Buy from Hold at Kepler Cheuvreux
ISRG Intuitive Surgical
$202.66 /

+0.605 (+0.30%)

ISRG Intuitive Surgical
$202.66 /

+0.605 (+0.30%)

ISRG Intuitive Surgical
$202.66 /

+0.605 (+0.30%)

ISRG Intuitive Surgical
$202.66 /

+0.605 (+0.30%)

On The Fly
Fly Intel: Pre-market Movers » 08:59
06/30/22
06/30
08:59
06/30/22
08:59
UHS

Universal Health

$107.27 /

+1.245 (+1.17%)

, SYM

Symbotic

$11.89 /

-1.93 (-13.97%)

, BNTX

BioNTech

$142.08 /

+2.245 (+1.61%)

, ASPN

Aspen Aerogels

$8.46 /

-6.25 (-42.49%)

, AYI

Acuity Brands

$156.04 /

+1.74 (+1.13%)

, POWW

AMMO

$4.08 /

-0.01 (-0.24%)

, STZ

Constellation Brands

$243.69 /

-1.84 (-0.75%)

, WBA

Walgreens Boots Alliance

$40.88 /

-0.07 (-0.17%)

, SGH

SGH

$20.28 /

-0.205 (-1.00%)

, DCT

Duck Creek Technologies

$18.43 /

-0.32 (-1.71%)

, HYPR

Hyperfine

$2.75 /

+0.6 (+27.91%)

, PFE

Pfizer

$50.94 /

+0.27 (+0.53%)

, WMT

Walmart

$121.83 /

-0.55 (-0.45%)

Check out this morning's…

ShowHide Related Items >><<
WMT Walmart
$121.83 /

-0.55 (-0.45%)

WBA Walgreens Boots Alliance
$40.88 /

-0.07 (-0.17%)

UHS Universal Health
$107.27 /

+1.245 (+1.17%)

SYM Symbotic
$11.89 /

-1.93 (-13.97%)

STZ Constellation Brands
$243.69 /

-1.84 (-0.75%)

SGH SGH
$20.28 /

-0.205 (-1.00%)

POWW AMMO
$4.08 /

-0.01 (-0.24%)

PFE Pfizer
$50.94 /

+0.27 (+0.53%)

HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

DCT Duck Creek Technologies
$18.43 /

-0.32 (-1.71%)

BNTX BioNTech
$142.08 /

+2.245 (+1.61%)

AYI Acuity Brands
$156.04 /

+1.74 (+1.13%)

ASPN Aspen Aerogels
$8.46 /

-6.25 (-42.49%)

UHS Universal Health
$107.27 /

+1.245 (+1.17%)

06/16/22 Loop Capital
Loop starts Universal Health at Hold on behavioral health staffing concerns
06/16/22 Loop Capital
Universal Health initiated with a Hold at Loop Capital
05/03/22 Mizuho
Universal Health price target lowered to $153 from $164 at Mizuho
04/28/22 Wells Fargo
Universal Health price target lowered to $118 from $139 at Wells Fargo
SYM Symbotic
$11.89 /

-1.93 (-13.97%)

06/23/22 Deutsche Bank
Symbotic initiated with a Buy at Deutsche Bank
06/23/22 Baird
Symbotic initiated with an Outperform at Baird
06/21/22 Cowen
Symbotic initiated with an Outperform at Cowen
05/16/22 Northland
SVF Investment Corp. 3 initiated with an Outperform at Northland
BNTX BioNTech
$142.08 /

+2.245 (+1.61%)

06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
04/12/22 H.C. Wainwright
BioNTech price target lowered to $298 from $339 at H.C. Wainwright
04/11/22 H.C. Wainwright
H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab
04/05/22 Canaccord
BioNTech price target lowered to $300 from $450 at Canaccord
ASPN Aspen Aerogels
$8.46 /

-6.25 (-42.49%)

06/07/22 B. Riley
Aspen guidance 'very positive' despite bigger loss, says B. Riley
05/03/22 Canaccord
Aspen Aerogels price target lowered to $32 from $47 at Canaccord
04/29/22 B. Riley
Aspen Aerogels price target lowered to $44 from $59 at B. Riley
02/18/22 Benchmark
Aspen Aerogels price target lowered to $60 from $70 at Benchmark
AYI Acuity Brands
$156.04 /

+1.74 (+1.13%)

06/27/22 Credit Suisse
Acuity Brands price target lowered to $211 from $241 at Credit Suisse
06/23/22 William Blair
William Blair downgrades Acuity Brands after survey points to weaker demand
06/23/22 William Blair
Acuity Brands downgraded to Market Perform from Outperform at William Blair
06/17/22 Baird
Acuity Brands price target lowered to $188 from $210 at Baird
POWW AMMO
$4.08 /

-0.01 (-0.24%)

08/17/21 Lake Street
AMMO price target raised to $12 at Lake Street after beat and raise report
STZ Constellation Brands
$243.69 /

-1.84 (-0.75%)

06/28/22 Goldman Sachs
Constellation Brands to beat sales estimates in Q1, says Goldman Sachs
06/28/22 Goldman Sachs
Boston Beer downgraded to Sell from Neutral at Goldman Sachs
06/24/22 Barclays
Constellation Brands price target lowered to $272 from $283 at Barclays
06/21/22 UBS
Constellation Brands price target lowered to $270 from $285 at UBS
WBA Walgreens Boots Alliance
$40.88 /

-0.07 (-0.17%)

06/25/22 Barclays
Walgreens Boots Alliance price target lowered to $45 from $50 at Barclays
04/12/22 Cowen
Walgreens Boots Alliance price target lowered to $50 from $55 at Cowen
04/05/22 Deutsche Bank
Walgreens price target lowered to $46 from $52 at Deutsche Bank
04/05/22 UBS
Walgreens Boots Alliance price target lowered to $49 from $52 at UBS
SGH SGH
$20.28 /

-0.205 (-1.00%)

06/30/22 Stifel
SGH price target lowered to $32 from $45 at Stifel
06/30/22 Deutsche Bank
SGH price target lowered to $32 from $40 at Deutsche Bank
06/30/22 Barclays
SGH price target lowered to $22 from $30 at Barclays
04/06/22 Needham
SGH price target raised to $45 from $42.50 at Needham
DCT Duck Creek Technologies
$18.43 /

-0.32 (-1.71%)

06/30/22 Raymond James
Duck Creek Technologies price target lowered to $18 from $24 at Raymond James
06/30/22 Barclays
Duck Creek Technologies price target lowered to $21 from $25 at Barclays
04/04/22 Wolfe Research
Duck Creek Technologies downgraded to Peer Perform at Wolfe Research
04/01/22 Needham
Duck Creek Technologies price target lowered to $27 from $40 at Needham
HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

05/31/22 Evercore ISI
Hyperfine initiated with an Outperform at Evercore ISI
04/14/22 Wells Fargo
Hyperfine initiated with an Overweight at Wells Fargo
PFE Pfizer
$50.94 /

+0.27 (+0.53%)

06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
06/22/22 Piper Sandler
Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler
06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
WMT Walmart
$121.83 /

-0.55 (-0.45%)

06/27/22 Goldman Sachs
Walmart price target lowered to $138 from $160 at Goldman Sachs
06/17/22 Truist
Deal with Walmart an 'incremental positive' for Roku, says Truist
WMT Walmart
$121.83 /

-0.55 (-0.45%)

WBA Walgreens Boots Alliance
$40.88 /

-0.07 (-0.17%)

UHS Universal Health
$107.27 /

+1.245 (+1.17%)

STZ Constellation Brands
$243.69 /

-1.84 (-0.75%)

SGH SGH
$20.28 /

-0.205 (-1.00%)

POWW AMMO
$4.08 /

-0.01 (-0.24%)

PFE Pfizer
$50.94 /

+0.27 (+0.53%)

HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

DCT Duck Creek Technologies
$18.43 /

-0.32 (-1.71%)

BNTX BioNTech
$142.08 /

+2.245 (+1.61%)

AYI Acuity Brands
$156.04 /

+1.74 (+1.13%)

ASPN Aspen Aerogels
$8.46 /

-6.25 (-42.49%)

  • 30
    Jun
WMT Walmart
$121.83 /

-0.55 (-0.45%)

WBA Walgreens Boots Alliance
$40.88 /

-0.07 (-0.17%)

UHS Universal Health
$107.27 /

+1.245 (+1.17%)

STZ Constellation Brands
$243.69 /

-1.84 (-0.75%)

BNTX BioNTech
$142.08 /

+2.245 (+1.61%)

WMT Walmart
$121.83 /

-0.55 (-0.45%)

WBA Walgreens Boots Alliance
$40.88 /

-0.07 (-0.17%)

UHS Universal Health
$107.27 /

+1.245 (+1.17%)

SYM Symbotic
$11.89 /

-1.93 (-13.97%)

STZ Constellation Brands
$243.69 /

-1.84 (-0.75%)

SGH SGH
$20.28 /

-0.205 (-1.00%)

POWW AMMO
$4.08 /

-0.01 (-0.24%)

DCT Duck Creek Technologies
$18.43 /

-0.32 (-1.71%)

BNTX BioNTech
$142.08 /

+2.245 (+1.61%)

AYI Acuity Brands
$156.04 /

+1.74 (+1.13%)

ASPN Aspen Aerogels
$8.46 /

-6.25 (-42.49%)

WMT Walmart
$121.83 /

-0.55 (-0.45%)

WBA Walgreens Boots Alliance
$40.88 /

-0.07 (-0.17%)

UHS Universal Health
$107.27 /

+1.245 (+1.17%)

SYM Symbotic
$11.89 /

-1.93 (-13.97%)

STZ Constellation Brands
$243.69 /

-1.84 (-0.75%)

SGH SGH
$20.28 /

-0.205 (-1.00%)

POWW AMMO
$4.08 /

-0.01 (-0.24%)

PFE Pfizer
$50.94 /

+0.27 (+0.53%)

HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

DCT Duck Creek Technologies
$18.43 /

-0.32 (-1.71%)

BNTX BioNTech
$142.08 /

+2.245 (+1.61%)

Wednesday
Hot Stocks
Hyperfine CEO Dave Scott to step down, Scott Huennekens named interim CEO » 16:27
06/29/22
06/29
16:27
06/29/22
16:27
HYPR

Hyperfine

$2.75 /

+0.6 (+27.91%)

Hyperfine announced that…

Hyperfine announced that Dave Scott will step down from his role as president, CEO, and board member for personal reasons, effective July 29. Scott Huennekens, who currently serves as executive chairperson of the board, will succeed Scott as interim president and CEO, also effective July 29. The company is engaging in a search for a long-term CEO as it continues to execute its business strategy focused on commercial expansion of the Swoop system. The company will host a conference call to discuss the CEO transition today, June 29. Huennekens is a CEO, chairperson, board member, and entrepreneur, having been involved in more than 20 medtech startup, growth, and public companies. As interim president and CEO, Huennekens will oversee the ongoing expansion of Hyperfine.

ShowHide Related Items >><<
HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

05/31/22 Evercore ISI
Hyperfine initiated with an Outperform at Evercore ISI
04/14/22 Wells Fargo
Hyperfine initiated with an Overweight at Wells Fargo
HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

HYPR Hyperfine
$2.75 /

+0.6 (+27.91%)

Monday
Hot Stocks
Eargo announces up to $125M strategic investment from Patient Square Capital » 07:10
06/27/22
06/27
07:10
06/27/22
07:10
EAR

Eargo

$1.25 /

+0.07 (+5.93%)

Eargo announced it has…

Eargo announced it has signed a definitive agreement with Patient Square Capital to raise $100M through the sale of senior secured convertible notes, with an additional $25M future investment subject to certain conditions. The company intends to use the net proceeds of Patient Square's investment for working capital purposes, to fund the company's omni-channel growth strategy and to repay all of the company's approximately $15M in existing third-party debt as well as related pay-off expenses.Under the agreement, the company will issue $100M aggregate principal amount of senior secured convertible notes to Patient Square upon closing. Within 180 days of the issuance of the First Tranche Investment, the company expects to undertake a rights offering that will be registered under the Securities Act of 1933, as amended, pursuant to which its stockholders as of a record date to be determined will have the right to purchase their pro rata share of 375 million shares of newly issued common stock at a purchase price of $0.50 per share. If the rights offering is completed before 150 days following closing of the First Tranche Investment, and existing stockholders subscribe for at least 75 million of shares, total cash proceeds to Eargo increases to $137.5M. Any proceeds from the rights offering will be used to redeem the senior secured convertible notes and for general corporate purposes.

ShowHide Related Items >><<
EAR Eargo
$1.25 /

+0.07 (+5.93%)

EAR Eargo
$1.25 /

+0.07 (+5.93%)

09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 William Blair
William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
09/23/21 Wells Fargo
Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
09/23/21 William Blair
Eargo downgraded to Market Perform from Outperform at William Blair
EAR Eargo
$1.25 /

+0.07 (+5.93%)

Over a week ago
Recommendations
Inari Medical price target lowered to $100 from $130 at BTIG » 07:23
06/24/22
06/24
07:23
06/24/22
07:23
NARI

Inari Medical

$69.25 /

+5.97 (+9.43%)

BTIG analyst Marie…

BTIG analyst Marie Thibault lowered the firm's price target on Inari Medical to $100 from $130 but keeps a Buy rating on the shares as part of a broader research note on medical technology and digital health names. The pain across the sector has been indiscriminate, and many companies that still offer healthy fundamentals, strong operating track records, and important product pipelines are losing a large portion of their market value, the analyst tells investors in a research note. Thibault adds that she prefers stocks with large cash balances, a line of sight to cash flow-breakeven, consistent quarterly outperformance, and multiples that compare well against pre-COVID levels.

ShowHide Related Items >><<
NARI Inari Medical
$69.25 /

+5.97 (+9.43%)

NARI Inari Medical
$69.25 /

+5.97 (+9.43%)

06/21/22 Piper Sandler
Inari Medical initiated with an Overweight at Piper Sandler
03/23/22 BofA
Inari Medical reinstated with a Buy at BofA
03/14/22 Canaccord
Inari Medical price target lowered to $96 from $102 at Canaccord
02/24/22 SVB Securities
Inari Medical price target raised to $95 from $85 at SVB Leerink
NARI Inari Medical
$69.25 /

+5.97 (+9.43%)

  • 11
    Mar
NARI Inari Medical
$69.25 /

+5.97 (+9.43%)

Recommendations
DexCom price target lowered to $105 from $135 at BTIG » 07:22
06/24/22
06/24
07:22
06/24/22
07:22
DXCM

DexCom

$75.21 /

+3.57 (+4.98%)

BTIG analyst Marie…

BTIG analyst Marie Thibault lowered the firm's price target on DexCom to $105 from post-split $135 but keeps a Buy rating on the shares as part of a broader research note on medical technology and digital health names. The pain across the sector has been indiscriminate, and many companies that still offer healthy fundamentals, strong operating track records, and important product pipelines are losing a large portion of their market value, the analyst tells investors in a research note. Thibault adds that she prefers stocks with large cash balances, a line of sight to cash flow-breakeven, consistent quarterly outperformance, and multiples that compare well against pre-COVID levels.

ShowHide Related Items >><<
DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

06/01/22 Lake Street
Abbott approval for Libre 3 'a huge positive' for Tandem, says Lake Street
05/31/22 Piper Sandler
Abbott approval bodes well for DexCom, Tandem, says Piper Sandler
05/31/22 Stifel
DexCom M&A response should put an end to recent dislocation, says Stifel
05/31/22 BTIG
DexCom shares may be volatile after 'squashing' M&A report, says BTIG
DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

DXCM DexCom
$75.21 /

+3.57 (+4.98%)

Options
Intuitive Surgical call volume above normal and directionally bullish » 12:05
06/23/22
06/23
12:05
06/23/22
12:05
ISRG

Intuitive Surgical

$205.70 /

+4.79 (+2.38%)

Bullish option flow…

Bullish option flow detected in Intuitive Surgical with 4,440 calls trading, 2x expected, and implied vol increasing over 2 points to 50.55%. Jul-22 240 calls and Aug-22 95 puts are the most active options, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 0.45. Earnings are expected on July 21st.

ShowHide Related Items >><<
ISRG Intuitive Surgical
$205.70 /

+4.79 (+2.38%)

ISRG Intuitive Surgical
$205.70 /

+4.79 (+2.38%)

06/22/22 Deutsche Bank
Intuitive Surgical price target lowered to $225 from $300 at Deutsche Bank
05/17/22 Citi
Intuitive Surgical price target lowered to $305 from $360 at Citi
04/22/22 Evercore ISI
Intuitive Surgical price target lowered to $280 from $294 at Evercore ISI
04/22/22 Raymond James
Intuitive Surgical price target lowered to $330 from $334 at Raymond James
ISRG Intuitive Surgical
$205.70 /

+4.79 (+2.38%)

ISRG Intuitive Surgical
$205.70 /

+4.79 (+2.38%)

ISRG Intuitive Surgical
$205.70 /

+4.79 (+2.38%)

ISRG Intuitive Surgical
$205.70 /

+4.79 (+2.38%)

Initiation
Procept BioRobotics initiated with a Buy at B. Riley » 06:55
06/23/22
06/23
06:55
06/23/22
06:55
PRCT

Procept BioRobotics

$34.17 /

-0.67 (-1.92%)

B. Riley analyst Neil…

B. Riley analyst Neil Chatterji initiated coverage of Procept BioRobotics with a Buy rating and $53 price target. Adoption of its Aquablation robotic technology to treat prostate enlargement is expected to ramp while "robust clinical evidence," payor coverage and a sales force doubling should drive a revenue CAGR of over 80%, Chatterji tells investors.

ShowHide Related Items >><<
PRCT Procept BioRobotics
$34.17 /

-0.67 (-1.92%)

PRCT Procept BioRobotics
$34.17 /

-0.67 (-1.92%)

03/09/22 Guggenheim
Procept BioRobotics price target lowered to $40 from $55 at Guggenheim
10/11/21 Cowen
Procept BioRobotics initiated with Outperform, $50 target at Cowen
10/11/21 BofA
Procept BioRobotics initiated with a Buy at BofA
10/11/21 BofA
Procept BioRobotics initiated with a Buy at BofA
PRCT Procept BioRobotics
$34.17 /

-0.67 (-1.92%)

  • 15
    Sep
PRCT Procept BioRobotics
$34.17 /

-0.67 (-1.92%)

PRCT Procept BioRobotics
$34.17 /

-0.67 (-1.92%)

Recommendations
Intuitive Surgical price target lowered to $225 from $300 at Deutsche Bank » 07:06
06/22/22
06/22
07:06
06/22/22
07:06
ISRG

Intuitive Surgical

$194.19 /

+2.04 (+1.06%)

Deutsche Bank analyst…

Deutsche Bank analyst Imron Zafar lowered the firm's price target on Intuitive Surgical to $225 from $300 and keeps a Hold rating on the shares. Following an "underwhelming" April and May, U.S. da Vinci sales data were "robust across the board," Zafar tells investors in a research note. U.S. procedures, revenues per procedure, and thus total revenues are all tracking meaningfully ahead of forecasts, says the analyst.

ShowHide Related Items >><<
ISRG Intuitive Surgical
$194.19 /

+2.04 (+1.06%)

ISRG Intuitive Surgical
$194.19 /

+2.04 (+1.06%)

05/17/22 Citi
Intuitive Surgical price target lowered to $305 from $360 at Citi
04/22/22 Evercore ISI
Intuitive Surgical price target lowered to $280 from $294 at Evercore ISI
04/22/22 Raymond James
Intuitive Surgical price target lowered to $330 from $334 at Raymond James
04/22/22 Bernstein
Bernstein calls Intuitive Surgical 'top pick,' would buy on weakness
ISRG Intuitive Surgical
$194.19 /

+2.04 (+1.06%)

ISRG Intuitive Surgical
$194.19 /

+2.04 (+1.06%)

ISRG Intuitive Surgical
$194.19 /

+2.04 (+1.06%)

ISRG Intuitive Surgical
$194.19 /

+2.04 (+1.06%)

Conference/Events
Jefferies to hold a conference » 04:55
06/22/22
06/22
04:55
06/22/22
04:55
ABST

Absolute Software

$8.16 /

+0.25 (+3.16%)

, BANR

Banner Corp.

$55.97 /

+1.93 (+3.57%)

, CDW

CDW

$159.89 /

+3.39 (+2.17%)

, DGII

Digi International

$23.26 /

+0.55 (+2.42%)

, SKIN

Beauty Health

$11.78 /

+0.52 (+4.62%)

, XPOF

Xponential Fitness

$12.85 /

-0.02 (-0.16%)

, ATRI

Atrion

$624.30 /

-7.32 (-1.16%)

, CCMP

CMC Materials

$174.42 /

+1.68 (+0.97%)

, DEN

Denbury

$67.13 /

+3.42 (+5.37%)

, LNDC

Landec

$10.11 /

+0.36 (+3.69%)

, SKLZ

Skillz

$1.39 /

+0.045 (+3.35%)

, TRNS

Transcat

$59.18 /

+0.24 (+0.41%)

, TCX

Tucows

$40.93 /

-0.96 (-2.29%)

, TBI

TrueBlue

$16.83 /

+0.585 (+3.60%)

, SCHL

Scholastic

$35.53 /

+0.04 (+0.11%)

, SBEV

Splash Beverage

$2.06 /

+0.24 (+13.19%)

, EBET

EBET

$2.62 /

-0.125 (-4.55%)

, BEST

Best Inc.

$1.22 /

+0.01 (+0.83%)

, BDSX

Biodesix

$1.33 /

-0.12 (-8.28%)

, CHKP

Check Point

$120.11 /

+0.71 (+0.59%)

, CHEK

Check-Cap

/

+

, EAR

Eargo

$1.03 /

-0.02 (-1.90%)

, LVLU

Lulu's Fashion Lounge

$12.27 /

-0.4 (-3.16%)

, LMND

Lemonade

$17.70 /

+0.215 (+1.23%)

Consumer Conference to be…

Consumer Conference to be held in Nantucket, MA on June 20-22.

ShowHide Related Items >><<
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TCX Tucows
$40.93 /

-0.96 (-2.29%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SCHL Scholastic
$35.53 /

+0.04 (+0.11%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

EAR Eargo
$1.03 /

-0.02 (-1.90%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CHEK Check-Cap
/

+

CDW CDW
$159.89 /

+3.39 (+2.17%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

05/11/22 BMO Capital
Absolute Software price target lowered to C$12 from C$14 at BMO Capital
05/11/22 Canaccord
Absolute Software price target lowered to $17 from $22 at Canaccord
02/09/22 BMO Capital
Absolute Software price target lowered to C$14 from C$18.50 at BMO Capital
02/09/22 TD Securities
TD Securities upgrades Absolute Software to Buy after 'another' beat and raise
BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

06/17/22 Stephens
Stephens upgrades Banner to Overweight as Street mismodels rate sensitivity
06/17/22 Stephens
Banner Corp. upgraded to Overweight from Equal Weight at Stephens
01/24/22 Raymond James
Banner Corp. price target raised to $72 from $68 at Raymond James
09/07/21 DA Davidson
Banner Corp. downgraded to Neutral from Buy at DA Davidson
CDW CDW
$159.89 /

+3.39 (+2.17%)

05/05/22 Evercore ISI
CDW removed from 'TAP Outperform' list at Evercore ISI
04/18/22 Evercore ISI
CDW added to 'TAP Outperform' list at Evercore ISI
04/14/22 Stifel
CDW upgraded to Buy at Stifel following recent pullback
04/14/22 Stifel
CDW upgraded to Buy from Hold at Stifel
DGII Digi International
$23.26 /

+0.55 (+2.42%)

06/01/22 Stephens
Digi International initiated with an Overweight at Stephens
02/03/22 Canaccord
Digi International price target raised to $30 from $28 at Canaccord
11/11/21 Roth Capital
Digi International price target raised to $33 from $28 at Roth Capital
11/11/21 Canaccord
Digi International price target raised to $28 from $25 at Canaccord
SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

05/11/22 Canaccord
Beauty Health price target lowered to $22 from $27 at Canaccord
05/11/22 DA Davidson
Beauty Health price target lowered to $24 from $35 at DA Davidson
05/11/22 Piper Sandler
Beauty Health price target lowered to $24 from $26 at Piper Sandler
04/28/22 Piper Sandler
Beauty Health price target lowered to $26 from $31 at Piper Sandler
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
03/14/22 Evercore ISI
Evercore ISI starts Xponential Fitness at Outperform with $34 price target
03/14/22 Evercore ISI
Xponential Fitness initiated with an Outperform at Evercore ISI
03/14/22 Baird
Xponential Fitness price target raised to $28 from $26 at Baird
ATRI Atrion
$624.30 /

-7.32 (-1.16%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

04/07/22 CL King
CMC Materials downgraded to Neutral from Buy at CL King
04/07/22 CL King
CMC Materials downgraded to Neutral from Buy at CL King
02/04/22 Mizuho
CMC Materials downgraded to Neutral from Buy at Mizuho
12/17/21 Citi
CMC Materials upgraded to Neutral after buyout at Citi
DEN Denbury
$67.13 /

+3.42 (+5.37%)

05/24/22 Citi
California Resources, Denbury may be takeout targets, says Citi
05/10/22 Citi
Denbury initiated with a Buy at Citi
05/05/22 Stifel
Denbury price target raised to $129 from $126 at Stifel
04/26/22 KeyBanc
KeyBanc says Axios report positive for Plug Power, other fuel cell names
LNDC Landec
$10.11 /

+0.36 (+3.69%)

04/06/22 Barrington
Landec downgraded to Market Perform from Outperform at Barrington
09/30/21 Barrington
Landec price target lowered to $12 from $14 at Barrington
SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

05/23/22 Citi
Skillz downgraded to Neutral from Buy at Citi
03/01/22 Citi
Skillz price target lowered to $5 from $9 at Citi
02/24/22 Stifel
Skillz price target lowered to $3.50 from $16 at Stifel
02/24/22 Wedbush
Skillz price target lowered to $7.50 from $25 at Wedbush
TRNS Transcat
$59.18 /

+0.24 (+0.41%)

06/02/22 H.C. Wainwright
Transcat price target lowered to $85 from $105 at H.C. Wainwright
05/26/22 Roth Capital
Transcat price target lowered to $80 from $97 at Roth Capital
05/25/22 Craig-Hallum
Transcat price target lowered to $81 from $94 at Craig-Hallum
02/03/22 Craig-Hallum
Pullback in Transcat shares creates buying opportunity, says Craig-Hallum
TCX Tucows
$40.93 /

-0.96 (-2.29%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

05/26/22 BMO Capital
TrueBlue downgraded to Market Perform from Outperform at BMO Capital
04/11/22 Sidoti
TrueBlue reinstated with a Buy at Sidoti
10/26/21 Baird
TrueBlue price target raised to $35 from $31 at Baird
SCHL Scholastic
$35.53 /

+0.04 (+0.11%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

04/25/22 EF Hutton
Splash Beverage initiated with a Buy at EF Hutton
EBET EBET
$2.62 /

-0.125 (-4.55%)

02/07/22 Needham
Needham starts Esports Technologies at Buy on esports betting opportunity
02/07/22 Needham
Esports Technologies initiated with a Buy at Needham
BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

06/13/22 Canaccord
Biodesix's Medicare coverage a meaningful milestone, says Canaccord
05/12/22 Canaccord
Biodesix price target lowered to $7 from $10 at Canaccord
04/20/22 Cowen
Biodesix initiated with an Outperform at Cowen
04/18/22 BTIG
Biodesix price target lowered to $10 from $17 at BTIG
CHKP Check Point
$120.11 /

+0.71 (+0.59%)

05/23/22 Jefferies
Check Point price target lowered to $130 from $145 at Jefferies
04/28/22 Barclays
Check Point price target lowered to $145 from $160 at Barclays
04/28/22 Credit Suisse
Check Point price target raised to $115 from $105 at Credit Suisse
04/28/22 Wells Fargo
Check Point price target lowered to $130 from $144 at Wells Fargo
CHEK Check-Cap
/

+

02/07/22
Check-Cap upgraded to Buy from Neutral at Dawson James
EAR Eargo
$1.03 /

-0.02 (-1.90%)

09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 William Blair
William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
09/23/21 Wells Fargo
Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
09/23/21 William Blair
Eargo downgraded to Market Perform from Outperform at William Blair
LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

06/10/22 BofA
Lulu's Fashion Lounge downgraded to Neutral from Buy at BofA
01/14/22 Jefferies
Jefferies still believes in strength of Lulu's model after management meetings
12/06/21 Cowen
Cowen starts Lulu's Fashion Lounge with Outperform, affordable luxury brand
12/06/21 Baird
Baird starts Lulu's Fashion Lounge with Outperform, sees attractive value
LMND Lemonade
$17.70 /

+0.215 (+1.23%)

05/11/22 Oppenheimer
Lemonade price target lowered to $30 from $45 at Oppenheimer
05/11/22 JMP Securities
Lemonade price target lowered to $40 from $95 at JMP Securities
02/25/22 Barclays
Lemonade price target lowered to $22 from $43 at Barclays
02/25/22 Oppenheimer
Lemonade price target lowered to $45 from $85 at Oppenheimer
XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

DGII Digi International
$23.26 /

+0.55 (+2.42%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CHEK Check-Cap
/

+

CDW CDW
$159.89 /

+3.39 (+2.17%)

CCMP CMC Materials
$174.42 /

+1.68 (+0.97%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

ABST Absolute Software
$8.16 /

+0.25 (+3.16%)

  • 07
    Apr
  • 15
    Feb
  • 11
    Nov
  • 23
    Jul
LMND Lemonade
$17.70 /

+0.215 (+1.23%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

XPOF Xponential Fitness
$12.85 /

-0.02 (-0.16%)

TRNS Transcat
$59.18 /

+0.24 (+0.41%)

TBI TrueBlue
$16.83 /

+0.585 (+3.60%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LVLU Lulu's Fashion Lounge
$12.27 /

-0.4 (-3.16%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

DEN Denbury
$67.13 /

+3.42 (+5.37%)

CHKP Check Point
$120.11 /

+0.71 (+0.59%)

CDW CDW
$159.89 /

+3.39 (+2.17%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

SKLZ Skillz
$1.39 /

+0.045 (+3.35%)

SKIN Beauty Health
$11.78 /

+0.52 (+4.62%)

SBEV Splash Beverage
$2.06 /

+0.24 (+13.19%)

LNDC Landec
$10.11 /

+0.36 (+3.69%)

LMND Lemonade
$17.70 /

+0.215 (+1.23%)

EBET EBET
$2.62 /

-0.125 (-4.55%)

EAR Eargo
$1.03 /

-0.02 (-1.90%)

BEST Best Inc.
$1.22 /

+0.01 (+0.83%)

BDSX Biodesix
$1.33 /

-0.12 (-8.28%)

BANR Banner Corp.
$55.97 /

+1.93 (+3.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.